IL130287A0 - Phosphodiesterase 8a - Google Patents

Phosphodiesterase 8a

Info

Publication number
IL130287A0
IL130287A0 IL13028798A IL13028798A IL130287A0 IL 130287 A0 IL130287 A0 IL 130287A0 IL 13028798 A IL13028798 A IL 13028798A IL 13028798 A IL13028798 A IL 13028798A IL 130287 A0 IL130287 A0 IL 130287A0
Authority
IL
Israel
Prior art keywords
polypeptides
polynucleotides
pde8
expression constructs
phosphodiesterase
Prior art date
Application number
IL13028798A
Other languages
English (en)
Original Assignee
Icos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25491965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL130287(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Icos Corp filed Critical Icos Corp
Publication of IL130287A0 publication Critical patent/IL130287A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Cereal-Derived Products (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13028798A 1997-10-16 1998-10-16 Phosphodiesterase 8a IL130287A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/951,648 US5932465A (en) 1997-10-16 1997-10-16 Phosphodiesterase 8A
PCT/US1998/021956 WO1999019495A1 (fr) 1997-10-16 1998-10-16 Phosphodiesterase 8a

Publications (1)

Publication Number Publication Date
IL130287A0 true IL130287A0 (en) 2000-06-01

Family

ID=25491965

Family Applications (3)

Application Number Title Priority Date Filing Date
IL13028798A IL130287A0 (en) 1997-10-16 1998-10-16 Phosphodiesterase 8a
IL130287A IL130287A (en) 1997-10-16 1999-06-03 Phosphodiesterase 8a
IL175698A IL175698A0 (en) 1997-10-16 2006-05-17 Phosphodiesterase 8a

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL130287A IL130287A (en) 1997-10-16 1999-06-03 Phosphodiesterase 8a
IL175698A IL175698A0 (en) 1997-10-16 2006-05-17 Phosphodiesterase 8a

Country Status (14)

Country Link
US (4) US5932465A (fr)
EP (2) EP1571216A3 (fr)
JP (1) JP2001512327A (fr)
CN (2) CN1800399A (fr)
AT (1) ATE295423T1 (fr)
AU (1) AU1097499A (fr)
BR (1) BR9806318A (fr)
CA (1) CA2275135A1 (fr)
DE (1) DE69830143T2 (fr)
ES (1) ES2245485T3 (fr)
IL (3) IL130287A0 (fr)
NO (1) NO992916L (fr)
RU (2) RU2272841C2 (fr)
WO (1) WO1999019495A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2238283C (fr) 1997-05-30 2002-08-20 Cell Pathways, Inc. Methode d'identification de composes visant a inhiber les lesions neoplasiques, compositions pharmaceutiques a prtir de ces composes et compositions pour traiter les lesions neoplasiques
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
EP0967284A1 (fr) * 1998-05-28 1999-12-29 Pfizer Limited Phosphodiestérases
US6130053A (en) * 1999-08-03 2000-10-10 Cell Pathways, Inc. Method for selecting compounds for inhibition of neoplastic lesions
GB9922125D0 (en) 1999-09-17 1999-11-17 Pfizer Ltd Phosphodiesterase enzymes
US6673564B2 (en) * 1999-10-18 2004-01-06 Millennium Pharmaceuticals, Inc. Methods for using 22045, a human cyclic nucleotide phosphodiesterase
CN1297049A (zh) * 1999-11-23 2001-05-30 上海博容基因开发有限公司 一种新的多肽——人环磷酸鸟嘌呤抑制的磷酸二酯酶17和编码这种多肽的多核苷酸
US6555547B1 (en) 2000-02-28 2003-04-29 Cell Pathways, Inc. Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative
US6569638B1 (en) 2000-03-03 2003-05-27 Cell Pathways, Inc Method for screening compounds for the treatment of neoplasia
CN1312381A (zh) * 2000-03-07 2001-09-12 上海博德基因开发有限公司 一种新的多肽——人环腺苷酸磷酸二脂酶13和编码这种多肽的多核苷酸
ATE373717T1 (de) * 2000-09-12 2007-10-15 Univ Washington Pde8a und seine verwendung
IL159722A0 (en) * 2001-07-10 2004-06-20 Oligos Etc Inc Pharmaceutical compositions containing oligonucleotides
WO2004042388A2 (fr) * 2002-11-08 2004-05-21 Bayer Healthcare Ag Diagnostics et medicaments pour des maladies associees a la phosphodiesterase 8a (pde8a) humaine
AU2005223847A1 (en) 2004-03-19 2005-09-29 Yale University Detection, isolation and uses of renalase (Monoamine Oxidase C)
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2630085A1 (fr) 2005-11-21 2007-05-24 Yale University Procedes de regulation de la renalase (monoamine oxydase c)
AU2008230710B2 (en) * 2007-03-27 2014-04-10 Omeros Corporation The use of PDE7 inhibitors for the treatment of movement disorders
JP6148007B2 (ja) * 2009-05-12 2017-06-14 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． 前立腺癌マーカーとしてのホスホジエステラーゼ４ｄ７
SG193024A1 (en) * 2011-03-11 2013-10-30 Synageva Biopharma Corp Npp1 fusion proteins
RU2760943C2 (ru) * 2011-09-15 2021-12-01 Алексион Фармасьютикалз, Инк. Гибридные белки NPP1
EP2804603A1 (fr) 2012-01-10 2014-11-26 President and Fellows of Harvard College Composés promoteurs de réplication des cellules bêta et leurs procédés d'utilisation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3501286B2 (ja) * 1989-12-22 2004-03-02 アプライド リサーチ システムズ，エーアールエス ホールディング ナームロゼ ベノートスハップ 一定の細胞系又は微生物の内因性遺伝子の発現特徴の変性のための方法
EP0539573A4 (en) * 1991-05-15 1993-12-29 Cell Genesys, Inc. Genomic modifications with homologous dna targeting
TW402639B (en) * 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
US5798246A (en) * 1996-03-25 1998-08-25 Incyte Pharmaceuticals, Inc. Cyclic nucleotide phosphodiesterase

Also Published As

Publication number Publication date
EP1571216A2 (fr) 2005-09-07
EP0944725B1 (fr) 2005-05-11
NO992916L (no) 1999-08-06
AU1097499A (en) 1999-05-03
EP1571216A3 (fr) 2006-04-26
IL175698A0 (en) 2008-02-09
DE69830143D1 (en) 2005-06-16
JP2001512327A (ja) 2001-08-21
ES2245485T3 (es) 2006-01-01
US6133007A (en) 2000-10-17
US20030215919A1 (en) 2003-11-20
CN1229499C (zh) 2005-11-30
NO992916D0 (no) 1999-06-15
ATE295423T1 (de) 2005-05-15
EP0944725A1 (fr) 1999-09-29
CA2275135A1 (fr) 1999-04-22
WO1999019495A1 (fr) 1999-04-22
RU2005136013A (ru) 2007-05-27
CN1248291A (zh) 2000-03-22
RU2272841C2 (ru) 2006-03-27
DE69830143T2 (de) 2006-03-02
US5932465A (en) 1999-08-03
US6566087B1 (en) 2003-05-20
IL130287A (en) 2006-08-20
BR9806318A (pt) 2000-03-14
CN1800399A (zh) 2006-07-12

Similar Documents

Publication Publication Date Title
IL175698A0 (en) Phosphodiesterase 8a
AU3501197A (en) Human stem cell antigens, dna coding therefor and their use
ZA983148B (en) Modified TNFÓ, DNA encoding such modified TNFÓ and vacines comprising said TNFÓ and DNA.
WO1999042596A3 (fr) Phosphodiesterase 10
WO2000005367A3 (fr) Proteines humaines a domaines hydrophobes et adn codant pour ces proteines
PL336470A1 (en) Mammalian cytokin-like factor 7
WO2000029574A3 (fr) Genes associes a des inflammations
ZA9710288B (en) Novel genes encoding telomerase proteins.
WO2002059315A3 (fr) Nouveaux acides nucleiques et polypeptides et procedes de leur utilisation
WO2000029448A3 (fr) Proteines humaines a domaines hydrophobes et adn codant pour ces proteines
WO2000015798A3 (fr) Facteur de croissance transformant beta - 9 mammaliens (ztgfss9)
WO2001012660A3 (fr) Proteines humaines a domaines hydrophobes et adn codant pour ces proteines
WO1998057983A3 (fr) Proteine de mammifere de type facteur de croissance nerveuse
WO2001002563A3 (fr) Proteines humaines ayant des domaines hydrophobes et adn codant pour ces proteines
NO990666D0 (no) FremgangsmÕte for diversitets-kombinering, samt mottaker
WO2000021986A3 (fr) Genes de remodelage de matrice
WO1999009182A3 (fr) Proteines rab
WO2000040722A3 (fr) Genes de synthese de l'insuline
WO2000077179A3 (fr) Materiaux poly(adp-ribose) polymerase 2 humains et procedes
EP1017279A4 (fr) Procedes de regulation de l'expression du trka
EP1044216A4 (fr) MOLECULES D'ADN CODANT DES PROTEINES RECEPTRICES NUCLEAIRES HUMAINES, nNR7 ET nNR7-1
WO1999029720A3 (fr) Proteine 1 mammalienne a helice alpha
WO1998057986A3 (fr) Preprotachykinine b humaine
WO2000070036A3 (fr) Molecules exprimees dans l'hippocampe
EP0887416A3 (fr) Enzyme AFC1 humaine

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees